1570027155576201217

We must do better for blood cancer patients. Gamida Cell’s lead pipeline candidate #omidubicel is under review by the FDA as the first potential allogeneic hematopoietic stem cell therapy for patients with blood cancers in need of a stem cell transplant. https://t.co/vQ1UAwv86W https://t.co/78LvPlqfk3

Send us a message